Despite the varied outcomes and grades of our tumor samples, our analysis of CD83+ tumor cells revealed that a rare cell population is present in both IDHmut (7.7%) and IDHWT (3.78%) tumors (Fig. 1B–D). The gene discussed is CD83; the disease is neoplasm.